© 2022 Michigan State University Board of Trustees
Public Media from Michigan State University
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations
Health

MSU pushes potential Parkinson's drug to clinical trial

lisa-lapidus-laser.jpg
Courtesy - Michigan State University
/

Neurodegenerative disorders such as Parkinson’s and Alzheimer’s cost the U-S billions of dollars each year. Last year, a study supported by the National Institutes of Health found that in 2010, the cost of treating Alzheimer’s alone neared $215-billion.These devastating illnesses also take a huge emotional toll on both the victims and their loved ones.

Current State’s Kevin Lavery reports that a team at Michigan State University is studying a protein molecule that it feels may become a new drug in the fight against degenerative diseases.

They say they’re ready to make the leap to clinical trials. 

Related Content
News from WKAR will never be behind a paywall. Ever. We need your help to keep our coverage free for everyone. Please consider supporting the news you rely on with a donation today. You can support our journalism for as little as $5. Every contribution, no matter the size, propels our vital coverage. Thank you.